Table 3 Baseline echocardiographic characteristics
From: Impact of percutaneous ventricular septal defect closure on left ventricular remodeling and function
Measurements | Baseline [median (IQR)] | |
|---|---|---|
LVEDD (mm) | 40 (34–42) | |
LVESD (mm) | 24 (22–28) | |
LVEDV (ml) | 41(32–50.75) | |
LVESV (ml) | 25 (18–28) | |
LV mass (gm) | 49.5 (37.5–65) | |
LVEDD/BSA(mm/m2) | 46.51(45.45–52.56) | |
LVESD/BSA(mm/m2) | 31.69 (27.91–35.82) | |
LVEDV/BSA(ml/m2) | 52.56 (47.14–58.54) | |
LVESV/BSA(ml/m2) | 31.7 (25.58–34.69) | |
LV mass/BSA (gm/m2) | 62.4(55.2–78.85) | |
LVEDD Z-score | 1.2 (0.0175–1.76) | |
LVESD Z-score | 1.7 (0.59–2.49) | |
EF (%) | 65 (60–69) | |
VSD-AV distance | 5 (4–6.75) | |
VSD size LV (mm) | 10 (6–13) | |
VSD size RV (mm) | 6 (3.3–6.5) | |
Aneurysmal tissue [no (%)] | Incomplete | 10 (58.8%) |
Complete | 4 (23.6%) | |
No | 3 (17.6%) | |
Gradient across defect (mmHg) | 85 (75–93) |